Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunotherapeutic dosing regimens comprising pomalidomide and an anti-CS1 antibody for treating cancer

Immunotherapeutic dosing regimens comprising pomalidomide and an anti-CS1 antibody for treating cancer

US Patent 10925867 · Granted Feb 23, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methane and emissions reduction system2023
System and methodology for high pressure alternate path2022
Methane and emissions reduction system2022
Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma2019
Immunomodulatory compounds for the restoration of vitamin D sensitivity in vitam2014
Immunological uses of immunomodulatory compounds for vaccine and anti-infectious2014
Automatic wafer edge inspection and review system2009
Human phosphodiesterase IV isozymes2006
Human phosphodiesterase IV isozymes2006
Apparatus for shaping thin films in the near-edge regions of in-process semicond2005
Human phosphodiesterase IV isozymes2005
Human phosphodiesterase IV isozymes2002